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During development, environmental estrogens are able to induce an estrogen mimetic
action that may interfere with endocrine and neuroendocrine systems. The present
study investigated the effects on the reproductive function in female mice following
developmental exposure to pharmaceutical ethinylestradiol (EE2), the most widespread
and potent synthetic steroid present in aquatic environments. EE2 was administrated
in drinking water at environmentally relevant (ENVIR) or pharmacological (PHARMACO)
doses [0.1 and 1µg/kg (body weight)/day respectively], from embryonic day 10 until
postnatal day 40. Our results show that both groups of EE2-exposed females had
advanced vaginal opening and shorter estrus cycles, but a normal fertility rate compared
to CONTROL females. The hypothalamic population of GnRH neurons was affected by
EE2 exposure with a significant increase in the number of perikarya in the preoptic area
of the PHARMACO group and a modification in their distribution in the ENVIR group,
both associated with a marked decrease in GnRH fibers immunoreactivity in the median
eminence. In EE2-exposed females, behavioral tests highlighted a disturbed maternal
behavior, a higher lordosis response, a lack of discrimination between gonad-intact
and castrated males in sexually experienced females, and an increased anxiety-related
behavior. Altogether, these results put emphasis on the high sensitivity of sexually
dimorphic behaviors and neuroendocrine circuits to disruptive effects of EDCs.
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INTRODUCTION
Evidence that exposure to Endocrine Disrupting Chemicals (EDCs) during development
contributes to disturbing various parameters of animal and human reproductive function, such as
puberty onset, fertility, and behaviors, has been largely highlighted (Walker et al., 2014; Parent et al.,
2015). It is widely accepted that natural hormones and potentially EDCsmodulate the development
of the central and peripheral nervous systems, including the setting of neuroendocrine circuits
controlling physiological and behavioral outcomes of reproductive function (McCarthy, 2008;
Gore et al., 2011). In mammals, hypothalamic neuroendocrine circuits orchestrating the pituitary-
gonadal activity are established during prenatal, early postnatal, and juvenile periods under the
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organizational effects of specific patterns of endogenous
estrogens, leading to masculinization or feminization of a
bipotential developing brain (McCarthy, 2008). In male, late
fetal and postnatal testosterone aromatized to estradiol is
responsible for neuroanatomical and functional masculinization
of neuroendocrine circuits, leading to the expression of adult
male typical sexual behaviors (Bakker, 2003). In female, perinatal
brain develops in much lower steroid hormones and is protected
from maternal estrogens by the alpha-fetoprotein, which binds
estradiol with high affinity (Bakker et al., 2006). Thus, disruption
of the ongoing patterns of estrogens during development may
durably alter the establishment of neuroendocrine networks
and consequently affect physiological, neuroendocrine and
behavioral components of reproductive function in adulthood.
Pharmaceutical 17α-ethinylestradiol (EE2) is a potent
estrogenic compound that is used mainly in oral contraceptives.
EE2 is among the most dominant environmental estrogens
(Snyder et al., 2001; Pojana et al., 2004; Laurenson et al., 2014).
Its concentration in aquatic environments is highly variable
according to environmental localization throughout the world.
In the USA and Europe, EE2 has been detected in surface
water at concentrations ranging from non-detectable to 273
ng.L−1 (Pojana et al., 2004; Hannah et al., 2009). In Asia, EE2
concentrations are largely higher, reaching 4100 ng.L−1 in some
wastewater treatment plants (WTPs) in Beijing (Zhou et al.,
2012). Moreover, a low rate of EE2 removal from wastewater
(20%) may considerably contribute to its bioaccumulation in
WTP outputs and potentially in natural aquatic environments
(Ternes et al., 1999; Balsiger et al., 2010). Given the concern
raised by the large EE2 pollution, it has thus received increasing
attention and, recently, the European Parliament and the Council
of Europe added EE2 to the priority “Watch list” of substances
presenting a significant risk to or via aquatic environments
according to the Environmental Quality Standards (Directive
2013/39/EU)1. Due to its high estrogenic potency and the fact
that it does not bind to alpha-fetoprotein (Sheehan and Branham,
1987), EE2 can affect endocrine and neuroendocrine systems,
and consequently impair the ability of wildlife and humans to
reproduce (National Toxicology Program, 2010).
Reproduction is controlled by the hypothalamic
Gonadotropin-Releasing Hormone (GnRH) neurons (Knobil,
1988; Wierman et al., 2011). This neuroendocrine network
constitutes the final output of the hypothalamus, that regulates
reproduction after integrating numerous signals coming
from the organism, such as circulating sex hormones, and
from the environment (Herbison, 2008). The present study
investigated whether developmental sub-chronic exposure
to an environmental-range or a pharmacological dose of
EE2 from critical fetal and perinatal periods up to puberty
disturbed reproductive function in adult female mice, including
physiological and behavioral parameters, and neuroendocrine
networks regulating the hypothalamic-pituitary-gonadal (HPG)
axis.
We already demonstrated in our laboratory that exposure to
EE2 altered ontogenesis of GnRH neurons in mouse embryos,
1http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32013L0039.
by increasing the number of these neurons (Pillon et al., 2012).
In this previous study, embryos were exposed during a short
period to specifically target GnRHneuron neurogenesis and nasal
migration, which occur between embryonic day (E) E10 and
E13 in mouse. In the current study, we investigated whether
this alteration may persist into adulthood in females exposed
to EE2 from fetal to peripubertal life. The neuroanatomy of
the hypothalamic GnRH neuronal network was studied in adult
female mice, both in the preoptic area (POA) where most of the
GnRH cell bodies are scattered, and in the median eminence
(ME), in which most GnRH axonal terminals are concentrated.
As the highly estrogen-sensitive kisspeptin neuroendocrine
network closely regulates GnRH neurons activity to control
gonadotropins’ secretion (Piet et al., 2013; Yeo, 2013), we also
analyzed kisspeptin neurons immunoreactivity in the POA.
Since alterations in such main neuroendocrine networks should
impact on physiological reproductive parameters, we assessed
the onset of puberty, the length of the estrus cycle and its
regularity, and fertility in adult females. Moreover, perinatal and
peripubertal estrogens are known to exert a facilitator role on
female brain organization (Bakker et al., 2003) for the expression
of maternal (Keller et al., 2010) and socio-sexual (Bakker et al.,
2002) behaviors in adulthood. Thus, to test the hypothesis that
EE2-exposure during development may affect these behaviors in
adult females, we assessed maternal nurturing behaviors, mating
partner preference, and sexual receptivity. Finally, we evaluated
the anxiety level of adult females. Anxiety is known to be sensitive
to estrogens and estrogen-like molecules during brain sexual
differentiation (Farabollini et al., 1999; Dugard et al., 2001) and
may trigger several reproductive-related behavioral disorders
such as maternal care (Neumann, 2008).
MATERIALS AND METHODS
Animals
All experiments were conducted in accordance with the
European directive 2010/63/EU2 on the protection of animals
used for scientific purposes (agreement number E37-175-2) and
approved by an ethical committee for animal experimentation
(CEEA Val-de-Loire, Tours, France, C2EA-19). Fifteen pregnant
Swiss mice (F0), purchased from a commercial breeder (Charles
River—France), were divided into three groups: CONTROL
(n = 5), ENVIR (n = 5), and PHARMACO (n = 5)
(see Figure 1 for Experimental design). Mice were housed in
individual standard cages (45 × 25 × 15 cm3) and given free
access to food (Safe, Augy, France) and water, under controlled
temperature (22◦C), humidity (50–60%) and photoperiod cycle
(12 h light/12 h dark).
Ethinylestradiol Treatment
A stock solution of EE2 (Sigma Aldrich, Saint-Quentin-Fallavier,
France) was prepared in 100% ethanol at 1µg.mL−1. Dilutions
to final doses of exposure were prepared in drinking water.
The daily dose was calculated according to the animals’ weights
and their water consumption. Animals were exposed to EE2
2http://eur-lex.europa.eu/legal-content/FR/TXT/?uri=CELEX:32010L0063.
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FIGURE 1 | Experimental design. F1 females were exposed to 0.1 and 1µg of ethinylestradiol (EE2)/kg (body weight)/day, corresponding respectively to
environmentally-relevant (ENVIR) and pharmacological (PHARMACO) doses. Exposure began at embryonic day (E) 10 by exposing F0 pregnant and then lactating
dams through their drinking water until postnatal day (PND) 21. After weaning, F1 females continued to be exposed through drinking water until PND40. Vaginal
opening was assessed during the peripubertal period (PND23 to PND32). Neuroanatomical studies were performed on 8-week-old females. Estrus cyclicity was
assessed between 14 and 17 weeks of age. Maternal behavior was assessed on nulliparous females. Social-sexual preference tests were performed on
sexually-naïve females, lordosis behavior was then assessed in 7 trials which were followed by a second test of social-sexual preference. Anxiety-like behavior was
assessed in an elevated plus maze device. Finally, females were mated with fertile males to assess fecundity and fertility.
from embryonic day (E) E10 through pregnant dams’ (F0
generation) exposure to drinking water. After birth, pups were
sexed; litters were culled to four females and four males per
dam and returned to their mothers up to weaning. Animals
(F1 generation) continued to be exposed through feeding up
to weaning. After weaning, animals were separated from their
mothers and from the opposite sex individuals. Females were
housed in standard cages (4–5 females per cage) and continued
to be treated with EE2-containing drinking water until postnatal
day 40 (PND40) (Figure 1). The three groups were treated as
follows: two groups were exposed to EE2, the ENVIR group
exposed to 0.1µg/kg body weight (bw)/d (day) (n = 13
females), a dose corresponding to an exposure range found
in highly polluted environments (Mashchak et al., 1982), and
the PHARMACO group (n = 20 females) exposed to a
pharmacological dose of 1µg/kg bw/d of EE2 (Stanczyk et al.,
2013). The third group received vehicle without EE2 (CONTROL
group; n = 20 females).
Among the five F0 females in the ENVIR group, only three
were pregnant although vaginal plugs had been observed in
the five females, leading to the effective of 13 F1 females
in the ENVIR group (4 female’ pups for two females and
5 female’ pups for the third one), instead of 20 for the
CONTROL and PHARMACO groups (4 female’ pups for each
FO female).
This experimental design was established to study the effect
of EE2 on female and male reproductive function. Due to the
different aspects being assessed requiring different scheduling
and experimental procedures on animals (estrus cyclicity,
behavioral tests), female and male EE2 effects were studied
separately. Only the results obtained from female offspring are
presented here.
Reproductive Physiology
Body Weight
Females from the tree treatment groups were weighted from
PND22 up to PND92.
Vaginal Opening
The age at vaginal opening was assessed through daily visual
examination. Vaginal opening was observed each day from
PND23, until complete opening was detected on all the females.
Cyclicity in Adult Females
To evaluate the regularity of the estrus cycles, daily vaginal
smears were carried out over 3 weeks between postnatal weeks
14 and 18. Smears were collected by flushing the entrance of the
vagina with physiological saline, which was then colored with
methylene blue to visualize the cells under optical microscopy.
The stages of proestrus, estrus and metestrus/diestrus were
determined from the cytology observed on smears.
Fertility Study
Female fertility was assessed at the end of all the behavioral
analyses. Each 26-week-old female was housed with a fertile male
mouse for 1–14 days until a vaginal plug was observed. The
number of pups and litters were recorded for each experimental
group of females.
Neuroanatomical Studies
Tissues Collection and Preparation
Fifteen 8-week-old females (5 per group) were euthanized
using an intra-peritoneal injection of a lethal dose of sodium-
pentobarbital (100mg/kg). Intracardiac perfusions with a nitrite
buffer solution followed by a solution of phosphate buffer saline
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0.1M, pH 7.4 (PBS) with 4% paraformaldehyde (PBS 4% PFA)
were performed. The mouse heads were dissected and brains
removed and post-fixed in PBS 4% PFA for 24 h. Brains were
then immersed in 20% sucrose solution in PBS for cryoprotection
and stored at 4◦C. Each brain was embedded in TissuTek©
and frozen in Isopentane at −40◦C, before being sliced with
a cryostat into 20µm coronal sections collected on SuperFrost
glass slides (Menzel, Germany) and stored at −20◦C until
immuhistochemistry.
Immunohistochemistry for GnRH Neurons
Thirty serial coronal brain slices (Bregma 0.14 to Bregma 0.86;
Franklin and Paxinos, 1997) covering within a rostro-caudal axis
the median septum (MS), the Organum Vasculum of the Stria
Terminalis (OVLT) and the medial preoptic area (mPOA) from
each female were immunolabeled for GnRH perikarya. To label
GnRH terminal nerves in the median eminence (ME), three
coronal sections per female were selected from the rostral, medial
and caudal ME (Bregma −1.70, Bregma −1.94, and Bregma
−2.08 respectively; Franklin and Paxinos, 1997).
Brain slices were treated for 15min at room temperature
(RT) in PBS with 0.3 Triton X-100 (PBST) and 1% H2O2
to block endogenous peroxidases, and then rinsed three times
(3 × 5min). After being incubated for 1 h at RT in PBST and
10% of normal goat serum (PBST-NGS) to reduce background
noise, slices were incubated in the primary antibody 19,900
rabbit IgG (1:3000) (Geller et al., 2013) diluted in PBST-NGS
overnight at 4◦C. For GnRH perikarya labeling, sections were
rinsed three times (3× 5min) in PBS and incubated for 2 h at RT
with the secondary biotinylated anti-rabbit immunoglobulin goat
antibody (Vector Lab) diluted at 1:500 in PBST-NGS. Slices were
washed twice in PBS and once in Tris-HCl buffer (0.05N, pH 7.6),
before being incubated for 1 h in ABC peroxidase (horseradish
peroxidase) complex [Vector Laboratories, Burlingame, CA,
USA kit Vectastain Elite (PK6100)] at a dilution of 1:600 in PBST.
The signal was revealed with 3.3′′ diaminobenzidine (DAB) and
0.02% H2O2. The enzymatic reaction was stopped in Tris-HCL.
Finally, sections were dehydrated in graded alcohol and toluene,
and mounted with DEPEX.
GnRH terminal nerves in the ME sections were labeled
by rinsing three times in PBS and then incubating in the
secondary antibody goat anti-rabbit IgG Alexa 546 (Molecular
Probes) diluted at 1:1000 in PBST-NGS for 2 h at RT. The
secondary antibody was rinsed three times in PBS and nuclei
were counterstained with DAPI (1:1000) for 1min. Sections
were washed, mounted on glass slides and coverslipped with
Fluoromount-G (Southern Biotech, Birmingham, AL).
Analysis of GnRH Cells Bodies and Terminal Nerves
Counting of GnRH neurons perikarya was performed under
a light microscope at 20X magnification. One brain from the
ENVIR group presented high background noise with DAB
labeling and was excluded from this analysis. As GnRH neurons
perikarya are scattered in their distribution area and distinct
from each other, it is easy to identify individual GnRH labeled
neurons between the n and the n+1 slices according to their
neuroanatomical location (Zhu et al., 2015). Immunoreactive
perikarya in 30 serial slices within a rostro-caudal continuum
were counted (Bregma 0.14 to Bregma 0.86; Franklin and
Paxinos, 1997). The total number of summed neurons from the
30 slices per animal was compared between groups. Subsequently,
to compare GnRH neuron distributions, the number of neurons
from each five consecutive slices was summed to establish a
distribution curve of neurons from the MS up to the mPOA.
Analyses of GnRH terminal nerves in the ME were performed
using epifluorescence microscope images computerized with
Mercator Software (Explora Nova, La Rochelle, France). Under
a magnification of 20X, anatomical regions in the ME were
localized using DAPI labeling. A selected region was centered
in a rectangle of 10,000µm2 and labeling was observed at a
wavelength of 555 nm. The image was captured, digitalized and
thresholded to detect the GnRH immunolabeled area. This area
was automatically calculated and divided by the total surface of
the region to obtain a percentage. To get a surface of labeled
GnRH area, an average surface area was obtained from the three
sections corresponding to rostral, middle and caudal ME for each
animal. The final value of labeled area per group is a mean of the
GnRH surface for 5 animals.
Immunohistochemistry for Kisspeptin Neurons
Two coronal 20µm brain slices per female from the
periventricular preoptic nucleus (PVpo) (Bregma 0.02mm;
Franklin and Paxinos, 1997) were processed to immunostain
kisspeptin neurons (Clarkson et al., 2014). Slices were incubated
in PBS with 0.3 Triton X-100 and 10% of normal goat serum
(PBST-NGS) for 1 h at RT, and then in sheep anti-kisspeptin
antibody (AC053) at a dilution of 1:2000 (Franceschini et al.,
2013) at 4◦C overnight. The following day, slices were rinsed
three times (3 × 5min) with PBS, and then processed for
immunofluorescence labeling for 2 h at RT using Alexa 546-
conjugated donkey anti-sheep IgG second antibody (1:1000;
Molecular Probes). After three rinses in PBS, nuclei were
counterstained with DAPI (1:1000) and incubated for 1min.
Slides were rinsed in water and coverslipped with Fluoromount-
G (Southern Biotechnology, Birmingham, AL, USA), before
being stored in the dark at 4◦C.
Behavioral Analyses
Two weeks before starting the behavioral tests, females were
housed individually in a standard cage with free access to
food and water. Except for the elevated plus maze test, all the
behavioral tests were conducted under red light during the dark
phase of the dark/light cycle 2 h after lights off.
Maternal Behavior
Females were tested for induction of maternal behavior by
exposing them to cross-fostered newborn pups (Rosenblatt, 1967;
Keller et al., 2010). Individually housed 12- to 14-week-old
females were tested as nulliparous in their usual home cage
after replacing the top with a clear Plexiglas cover to allow
observation. Each female was allowed a 5-min habituation period
before maternal behavior was assessed for 30min. To this end,
3- to 5-day-old pups from another female were placed at the
opposite sides of the cage (three per female). Measures recorded
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were: the latency to retrieve the first pup to the nest, and then
the cumulative duration over the 30-min test for each of the
following behaviors: sniffing pups, licking/grooming, nursing
(arched-back position), nest building and self-grooming, while
other activities such as rearing, leaning or digging were recorded
as non-maternal care behaviors.
Lordosis Behavior
Lordosis behavior was assessed in transparent Plexiglas aquaria
during the first 2–5 h after lights off. To evaluate normal
physiological response, intact-estrus females were used. Each 17-
to 23-week-old female was tested seven times, once per estrus
cycle. Each estrus female was placed in the aquarium with a
stimulusmale for 20min. Stimulusmales were allowed to become
habituated to the aquaria with their own bedding at least 2 h
before introducing the female. The number of attemptedmounts,
successful mounts and lordosis postures (when pelvic thrusts
were observed) were scored. To avoid any unwanted pregnancies,
the male was removed from the female 3 s after intromission
(pelvic thrust). If females received 20 attempted or successful
mounts, the test was stopped before the end of the 20-min trial.
The lordosis quotient (LQ) was calculated as the number of
scored lordosis postures/total number of successful mounts ×
100. The first three trials served as experience acquisition for the
females and the LQ was scored from the fourth to the seventh
trial (Kercmar et al., 2014).
Social-Sexual Investigatory Behavior
The mating preference of females was evaluated through a choice
between a gonad-intact male and a castrated male. Females
were tested during estrus, first as sexually inexperienced (naïve),
and then after sexual interactions with males (16- and 24-
week-old respectively), in a Plexiglas device divided into three
compartments enabling free movement of the tested animal.
Lateral compartments were divided into two and the partition
had small holes at its base allowing diffusion of odors and
nose-to-nose contacts. The cumulative time spent in each lateral
compartment and the cumulative time spent sniffing each male
were recorded for 10min.
Elevated Plus Maze Test
An elevated plus maze test (EPM) was used to assess the anxiety
level of 25-week-old females. The EPM consists of two open and
two closed cross-shaped arms (5 cm wide× 40 cm long) elevated
50 cm from the floor. Each diestrus female was placed in the
central square and allowed to investigate the EPM arms for 5min.
The time spent in the two open and two closed arms and the
number of entries into each arm were recorded.
Statistical Analyses
Statistical analyses were performed with GraphPad prism5
software (GraphPad Software San Diego, CA). Normality of
distributions was tested using the D’Agostino and Pearson
omnibus normality test. A Two-way ANOVA with the
Bonferroni post-test was used to compare body weights
across animal age, and to compare and analyze lordosis behavior
data. A Chi2 test was used to compare the percentages of vaginal
opening and lordosis postures. Time spent sniffing gonad-intact
and castrated males in the sexual preference test were compared
using a paired t-test for each group. A One-way ANOVA with
the Bonferroni multiple comparison test was used to compare
the three groups of animals when distributions were Gaussian
and variances equal (Bartlett test) (estrus cycle length). If data
did not fit Gaussian distribution and/or variances were unequal,
we used a non-parametric Kruskal-Wallis with Dunn’s multiple-
comparison test (maternal behavior, anxiety-like behavior and
number of GnRH neurons). GnRH neurons distribution was
compared with an Extra sum-of-square-test F. Differences
were considered significant for p < 0.05. Non-parametric or
parametric data are respectively presented as Tukey’s boxplots or
as histograms (mean± SEM).
RESULTS
Reproductive Physiology
EE2 and Body Growth Curves
Two-way ANOVA showed that the kinetics of body weight
exhibited a significant overall effect of EE2-treatment [F(2,300) =
6.22, p = 0.002] and age [F(5,300) = 291.78, p < 0.0001]
on growth curve between PND22 and PND92. In spite of a
statistically significant effect of EE2-treatment, this accounts
for approximately 0.68% of the total variance against 80% for
age-effect. Bonferroni post-test did not show any statistically
significant effect of EE2 for both ENVIR and PHARMACO doses
at different ages (Figure 2A).
EE2 and Vaginal Opening
Vaginal opening was detected from PND24 in 15 and 10%
of the EE2-exposed females in the ENVIR and PHARMACO
groups respectively, whereas no vaginal opening was detected in
CONTROL females (Figure 2B). A Chi2 test revealed significant
earlier vaginal opening in EE2-exposed animals in PND24
and PND25 (p = 0.0007). In CONTROL females, the first
vaginal openings were detected at PND26 (Chi2 CONTROL
vs. PHARMACO, p = 0.05). Then, up to PND31 when all
the females of the three groups presented an opened vagina,
the proportion of females with vaginal opening was always
statistically higher in the EE2-exposed females than in the
unexposed CONTROL females. The Chi2 test revealed significant
differences in the cumulative percentages of female mice with
vaginal opening between the three experimental groups from
PND24 to PND31.
EE2 and Estrus Cyclicity
The estrus cyclicity of the adult females was assessed through
daily vaginal smears for a period of three estrous cycles beginning
at the 14th week of age. Histograms in Figure 2C show the
percentages of females which have completed a full cycle in four
successive days, i.e., females showing a return to the state of
the first day of the cycle on day 5 of daily vaginal smears. In
the CONTROL group, only 38% of females had accomplished
a complete cycle within 4 days, compared to 80 and 78% of
ENVIR and PHARMACO females respectively (p < 0.0001).
Thus, EE2-exposed females showed shortened estrus cycles.
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FIGURE 2 | Effects of developmental EE2 exposure on reproductive physiology. (A) Body weight of female mice exposed to the vehicle (Control; n = 20) or to
EE2 [ENVIR (n = 13) and PHARMACO (n = 20)] was evaluated from PND22 up to PND92. Data are expressed as means ± SEM. (B) Vaginal opening pattern for each
experimental group. Cumulative percentages of female mice showing vaginal opening according to age and experimental condition are presented from PND23 to
PND32. Dissimilar letters indicate significant differences at each PND, p < 0.05 using the Chi2 test of Pearson (a = ENVIR vs. Control. b = PHARMACO vs. Control.
(C,D) The estrus cycle was evaluated daily for 14- to 18-week-old females during three cycles. (C) Estrus cycle length given as a percentage of females showing a
complete cycle over four consecutive days (4 days) and females that did not complete a cycle over 5 days of vaginal cytology analyses (>4 days). Chi2 test comparing
Control vs. ENVIR or Control vs. PHARMACO groups, ***p < 0.001. (D) Average occurrence of proestrus/estrus (follicular phase) vs. metestrus/diestrus (luteal phase)
stages and per experimental group during 3 weeks of vaginal cytology analyses in adult females. One-way ANOVA (F = 4.32). *Tukey’s multiple comparison test;
*p < 0.05. Paired t-test: #p < 0.05; ###p < 0.001.
Analyses of follicular and luteal phases’ length show
that, for CONTROL females, 37% of the total cycle length
was proestrus/estrus, whereas for EE2-exposed ENVIR and
PHARMACO females proestrus/estrus represented about 43 and
49% of the total cycle length respectively [One-way ANOVA,
F(2,42) = 4.32, p = 0.01; Figure 2D). The Bonferroni multiple
comparison test showed that the lengths of the follicular and
luteal phases were statistically significantly different from the
CONTROL females only for the PHARMACO group (p < 0.05).
The intragroup comparison of the cycle phases’ lengths showed
that, in CONTROL females, the proestrus/estrus phase is highly
significantly shorter (37%) than the metestrus/diestrus phase
(63%) (paired t-test; ###p < 0.001). Within the ENVIR group,
the difference between the two phases was also significant (43%
in proestrus/estrus and 57% in metestrus/diestrus; #p < 0.05), as
it was not in PHARMACO females which spent 49 and 51% in
proestrus/estrus and metestrus/diestrus respectively.
EE2 and Fertility
No differences in fecundity and fertility were detected, since
the relative number of litters (100% CONTROL, ENVIR, and
PHARMACO mated females farrowed) and litter size (11.3 ±
0.8, 12.4 ± 1.1, and 10.5 ± 1.3 in CONTROL, ENVIR, and
PHARMACO respectively) did not vary. There was no difference
in sex ratio (number of males/number of females) between
the three groups: 0.96 ± 0.18, 1.21 ± 0.17, and 1.16 ± 0.26
in CONTROL, ENVIR, and PHARMACO groups respectively
(Kruskal-Wallis test, p = 0.70; data not shown).
Neuroanatomical Studies
EE2 and the Neuroendocrine GnRH System
The effects of developmental exposure to EE2 on the numbers
and neuroanatomical distribution of hypothalamic GnRH
neurons perikarya in adult female mice were assessed (Figure 3).
Immunohistochemical analysis of the GnRH neuroendocrine
network in the main areas of their perikarya distribution in the
median septum (MS), the Organum Vasculum of the Lamina
Terminalis (OVLT) and the medial preoptic area (mPOA)
revealed a statistically significant effect of EE2 treatment on the
number of neurons (Kruskal-Wallis test, p = 0.01) (Figure 3A).
Dunn’s multiple comparison test revealed a significant increase in
females exposed to the PHARMACO dose during development,
with an increase to 193% (304 ± 29 neurons) compared with the
CONTROL group (158 ± 30 neurons). No significant difference
was detected for the ENVIR group (171± 11 neurons) compared
to the CONTROL group. Figure 3D (upper panel) illustrates
these differences in GnRHneuron numbers in the OVLT between
the three groups.
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FIGURE 3 | EE2 altered the establishment of GnRH neuron network. (A)Total number of GnRH immunoreactive neurons in the POA for each experimental
group. (B) Curve fit of the distribution of GnRH neurons centered on the OVLT through a rostro-caudal axis from the median septum (-400µm) up to the medial
preoptic area mPOA (+400µm). Extra sum-of-square-test F(6,103) = 5.75, P < 0.0001. (C) Quantification of the labeled area of GnRH in three parts of the median
eminence (posterior, middle and anterior). Tukey’s box-plots of GnRH labeling according to the experimental group. The band is the median and (+) is the mean.
Kruskal-Wallis test; *p < 0.05. Dunn’s Multiple Comparison test (statistically different from Control). Numbers in brackets are effectives of animals per group. (D)
Representative photographs of immunohistochemical labeling with DAB-Ni staining of GnRH perikarya in the Organum Vasculum of the Lamina Terminalis (OVLT)
(upper panel) and immunohistochemical staining with fluorescence of GnRH fibers in the median eminence (ME) (lower panel). 3V: third ventricle. Scale bar = 100µm.
The neuroanatomical distribution of the GnRH neurons was
investigated through a rostro-caudal axis within a continuum
centered on the OVLT and extending from the MS (-400µm) up
to the mPOA (+400µm) (Figure 3B). The number of neurons
is indicated in each 100µm position by summing the number
of neurons from five serial slices. In CONTROL females, the
distribution shows a bell-shaped curve whose peak is located at
the OVLT level. Statistical comparison using an Extra sum-of-
square-test F shows statistically significant differences between
the three curves [F(6,103) = 5.75, p < 0.0001], indicating
that neuronal distribution in adult has been disturbed by EE2
developmental exposure (Figure 3B).
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Most of the hypothalamic GnRH neurons project their
axons into the ME. The analysis of the anterior, middle and
posterior parts of the ME from each animal allowed the
proportion of GnRH labeled area to be determined, reflecting
the density of GnRH fibers. In females that were developmentally
exposed to EE2 (ENVIR and PHARMACO groups), the GnRH
labeled area was significantly reduced. Results are shown in
Figure 3C, illustrated in Figure 3D microphotographs (lower
panel). Compared to the CONTROL group (12.1 ± 1.3%), the
reduction was about 46% in the ENVIR group (6.6 ± 1.2%), and
44% in the PHARMACO group (6.9 ± 1.5%) (Kruskal-Wallis
test, p = 0.02; Dunn’s multiple comparison test, ∗p < 0.05).
EE2 and Kisspeptin Neurons
Kisspeptin neurons were counted in two adjacent coronal slices
in the periventricular preoptic nucleus (PVpo) for each animal.
Figure 4A represents Tukey’s boxplots of the mean numbers in
the two slices for each animal of the three groups. As illustrated
in Figure 4B, no difference per slice per animal was detected
between CONTROL and EE2-exposed females, with 60 ± 9,
64 ± 3, and 64 ± 11 neurons in the CONTROL, ENVIR, and
PHARMACO groups respectively.
Behavioral Analyses
EE2 and Maternal Behavior
Females of the ENVIR group spent significantly more time
(980± 206 s) to retrieve the first pup to the nest than CONTROL
FIGURE 4 | The number of kisspeptin neurons was not disturbed by
EE2 exposure. (A) Tukey’s boxplots of the numbers of kisspeptin neurons
counted in the periventricular preoptic nucleus (PVpo). (+) is the mean,
numbers in brackets are effective of animals per group. No statistical
differences were detected. (B) Photomicrographs of coronal brain sections
counterstained with DAPI (blue) and immunostained for kisspeptin (red).
Arrowheads indicate kisspeptin perikarya along the third ventricle (3V). Scale
bar = 20µm.
and PHARMACO females (543 ± 159 s and 673 ± 152 s
respectively) (Kruskal-Wallis test, p = 0.05; Dunn’s multiple
comparison test, p < 0.05) (Table 1). EE2-treated females
spent significantly more time in activities that are not pups-
related (51.28 ± 7.78% and 41.69 ± 5.87% in the ENVIR and
PHARMACO groups, respectively), compared to the CONTROL
group (29.07 ± 6.44) (Kruskal-Wallis test, p = 0.04). No
statistically significant effect was observed for any of the other
evaluated parameters related to pups’ nursing (Table 1).
EE2 and Mate Preference
Mating preference tests on naïve females showed that females
from the three groups did not exhibit any preference for the
gonad-intact or the castrated male (Figure 5A). In contrast,
the sexually-experimented CONTROL females exhibited a
preference for the gonad-intact male over the castrated male (t-
test, t = 4.29; p = 0.009). This preference was found neither in
ENVIR females (t-test, t = 1.67; p = 0.14) nor in PHARMACO
females (t-test, t = 1.02; p = 0.3).
EE2 and Lordosis Behavior
A Two-way ANOVA test demonstrated an overall significant
effect of trial number [F(3, 143) = 2.95, p = 0.03] and EE2-
exposure on the lordosis quotient (LQ) [F(2, 143) = 3.94, p =
0.02]. As an example, during the seventh trial, PHARMACO
females showed a 200% increase in the LQ compared with the
CONTROL females (Figure 5B).
The percentages of females showing a lordosis posture were
also compared between the three different groups (Figure 5C).
During the fourth trial, 20% of the CONTROL females showed a
lordosis posture, vs. 11 and 33% of females in the ENVIR and
PHARMACO groups respectively. This rate increased to 33%
during the seventh trial for the CONTROL group vs. 63 and 60%
for the ENVIR and PHARMACO groups respectively. A Chi2 test
revealed a statistically significant increase (p = 0.0002) for the
ENVIR and PHARMACO groups (Figure 5C).
TABLE 1 | Maternal behavior tests.
Experimental Group
Scored parameter
Control (15) ENVIR (8) PHARMACO (15)
Latency to retrieve the first
pup to the nest
543± 159 s 980± 206*s 673±152 s
Sniffing 3.35± 0.70 4.20± 0.87 3.93±0.60
Licking/grooming 29.13± 3.5 22.57± 3.77 18.41±3.30
Arched-back nursing 23.28± 5.12 8.30± 3.52a 15.28±3.84
Nest building 9.94± 1.42 7.08± 1.04 11.51±2.46
Self-grooming 5.44± 1.28 6.56± 1.65 9.19±1.73
Not pups-related activities 29.07± 6.44 51.28± 7.78* 41.69±5.87
The latency to retrieve the first pup to the nest is shown in seconds (mean± SEM). Results
are mean percentages (±SEM) of time spent per animal in each scored behavior during
a 30-min test. *Kruskal Wallis test with Bonferroni multiple comparison (p < 0.05; ap =
0.06).
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FIGURE 5 | EE2 impaired social and sexual behaviors of females. (A) Sexual preference tested in naïve (without any contact with an adult male) and
experienced (after mating behavior tests) females at the estrus stage. Histograms present the time spent sniffing the gonad-intact or the castrated male over 10min.
*** Unpaired t-test comparing the average time spent by females with the gonad-intact or the castrated male. (B,C) Female sexual behavior (lordosis behavior):
females were tested on 7 trials at the day of estrus: for each female, a trial was carried out once per cycle. (B) Lordosis quotient (LQ): number of lordosis
postures/total number of successful mounts × 100. Two-way ANOVA, p = 0.02. (C) Percentages of females showing lordosis posture during behavioral tests. Chi2
test comparing each exposed group to the Control group for each trial. ap = 0.06; **p < 0.01; ***p < 0.001.
EE2 and Anxiety-Like Behavior
The EPM test revealed that EE2 treatment increased the anxiety-
like behavior of the F1 generation females in adulthood. Females
from the ENVIR and PHARMACO groups spent less time
in the open arms of the EPM device than the CONTROL
group (Kruskal-Wallis, p = 0.01, with ∗Bonferroni multiple
comparison; p < 0.001) (Figure 6A). EE2-exposure also
decreased significantly the number of entries into the open arms
from 17.1 ± 1.3 in the CONTROL group to 12.6 ± 1.1 in the
ENVIR group (p < 0.001) and 11.7 ± 0.6 in the PHARMACO
group (Kruskal-Wallis, p = 0.001; with ∗Bonferroni multiple
comparison) (Figure 6B).
DISCUSSION
The environmental EE2 contamination may be considered as
an emerging issue that might affect animal and human health1
(Owen and Jobling, 2012; Green et al., 2013). In the present
study, we investigated the long-term effects of a developmental
exposure to EE2 on reproductive function in female mice.
We demonstrated that chronic exposure to EE2 in drinking
water during critical phases from intrauterine development
until puberty, at doses in a range of environmental exposure
and much lower than the previously reported Low-Observed-
Adverse-Effect-Level (LOAEL) dose (Kanno et al., 2001), induced
enduring effects on reproductive function in females. Indeed,
we observed advanced vaginal opening and shortening of
estrous cyclicity. The GnRH neuroendocrine network, the main
regulator of the gonadotropic axis, was altered, suggesting
that neuroendocrine effects are involved. Moreover, behavioral
outcomes were disrupted, namely a decrease in maternal
nurturing behavior, a decrease in social-sexual preference, an
increased lordosis behavior and an increased anxiety level. All
these points will be discussed in the following paragraphs.
Developmental Exposure to EE2 Altered
Reproductive Physiology
Our results showed that EE2 developmental exposure induced
advanced vaginal opening and modifications of estrus cyclicity
at both ENVIR and PHARMACO doses. Fertility and fecundity
over one breeding period were not significantly affected by EE2
treatments.
We demonstrated that both doses of EE2 (0.1 and 1µg/kg
bw/d) significantly accelerated the vaginal opening when
compared with the CONTROL group. These results are broadly
consistent with several other studies in Sprague-Dawley rats
conducted at the National Center for Toxicological Research for
the National Toxicology Program (NTP) (National Toxicology
Program, 2010). In these studies, authors used rats treated
chronically with an oral dose range of 0.2–5.8µg/kg/day during
development up to PND140, using an experimental design
comparable to our treatment protocol, even though doses were
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FIGURE 6 | EE2-exposure increased anxiety of females. (A) Percentages of time spent in the open arms of an elevated plus maze (EPM) (Kruskal Wallis test;
p = 0.001). (B) Numbers of entries into the open arms of the EPM (Kruskal Wallis test; p = 0.01). Bonferroni multiple comparison test: *p < 0.05; *p < 0.001;
***p < 0.001.
notably higher than those used herein. Likewise, they found that
EE2 disturbed vaginal opening and estrus cycles at 5.8µg/kg/d,
but had no effect on fertility. Another study conducted with
Long-Evans rats (Ryan et al., 2010) showed that 5µg/kg/d of EE2
exposure from embryonic day 7 up to PND18 accelerated vaginal
opening, reduced body weight at vaginal opening and induced
some genital malformations in females.
In our study, EE2 exposure extended from gestation up
to PND40. As females were still exposed to EE2 at vaginal
opening, then the significant alteration of pubertal timing may
be the consequence of peripheral effects through a direct action
of EE2 on vagina epithelium, suggesting that the observed
advanced vaginal opening do not necessarily imply central
and/or ovarian pubertal changes. Nevertheless, the advanced
vaginal opening may also result from central effects through
an interference of EE2 with the neuroendocrine system during
critical developmental periods (Franssen et al., 2014). Indeed,
we found in adult females developmentally exposed to EE2 an
alteration in GnRH neurons neuroanatomical localization in the
POA and a decrease in their terminal nerves density in the
ME. During embryonic development, GnRH neurons migrate
from the olfactory placode through the nose up to their final
main localization in the median septum, rostral hypothalamus
and preoptic area (POA) (Schwanzel-Fukuda and Pfaff, 1989;
Wray et al., 1989). Delay in nasal to brain migration of GnRH
neurons has been associated with a delay in puberty and
disruption of estrus (Parkash et al., 2012), implying that the
onset of puberty is dependent on the correct timing of GnRH
neuron migration. Moreover, Rasier et al. (2007) demonstrated
that transient exposure to EDCs (estradiol, o, p′-DDT) in early
postnatal life can induce an early maturation of the pulsatile
GnRH secretion and a subsequent early developmental reduction
of LH response to GnRH, constituting a possible mechanism of
the sexual precocity.
We also demonstrated that exposure to EE2 induced
shortening of estrous cycles in the two treated groups, as well
as a proportional shortening metestrus/diestrus phase toward the
proestrus/estrus phase, all the more in the PHARMACO group.
The hypothalamic control of ovulation and estrous cycling is
developmentally organized (Foster et al., 2006) and the activity of
the GnRH secretion system is sexually differentiated during the
postnatal period. Therefore, exposure to some EDCs can cause
inappropriate sexual differentiation of the female hypothalamus
and alterations in estrous cyclicity after puberty (Gore, 2008).
We can suspect that the alterations that we detected in GnRH
network led to disruptions in patterns of pituitary gonadotropins
secretion, and consequently to altered production and secretion
of ovarian hormones regulating estrus cycle. Subsequently, it
will be interesting to investigate whether gonadotropic hormonal
levels are altered in EE2-exposed females.
Developmental Exposure toEE2Altered the
Establishment of GnRH Neuron Network
The present study showed that EE2 exposure during a period in
which GnRH neurons were developing led to an increase in the
number of these neurons mainly in the POA. A previous study
published by our laboratory already demonstrated that a short
exposure to EE2 during the neurogenesis and the nasal migration
of GnRH neurons between E10.5 and E13.5 led to a significant
increase in the number of these neurons in embryos (Pillon
et al., 2012). We now demonstrated that this increase in GnRH
neurons number in embryos is still detectable in adult females,
suggesting a developmental embryonic origin of this phenotype
at adulthood. Such an increase in the number of GnRH neurons
has already been reported after developmental EE2-exposure in
zebrafish (Vosges et al., 2012).
In a birth-date study using bromodesoxyuridine pulse labeling
during early GnRH neurons ontogeny, Jasoni et al. (2009)
described that early-bornGnRHneurons stopped theirmigration
in the most rostral areas, while later-born GnRH neurons settled
more caudally. In our study, in spite of the absence of difference
in GnRH neurons number between ENVIR and CONTROL
females, we detected a greater proportion of GnRH neurons
located at the OVLT level and more caudally in ENVIR females
Frontiers in Neuroscience | www.frontiersin.org 10 December 2015 | Volume 9 | Article 463
Derouiche et al. Ethinylestradiol and Female Gonadotropic Axis
than in the CONTROL group. This mislocalization may result
from defects in the neuronal migration occurring between E11
and E16 (Schwanzel-Fukuda and Pfaff, 1989; Parkash et al., 2012).
Furthermore, we observed a dramatic decrease in the
immunoreactivity of the GnRH terminal nerves for the ENVIR
and PHARMACO groups compared with the CONTROL group
in the ME. This difference in fibers immunofluorescence
density can be due to a developmental alteration disrupting
the axonal GnRH growth for projections, leading to a lowest
density of GnRH fibers in this brain area. Other studies
using an in vitro GT1-7 cell line reported that estrogenic
EDCs impaired GnRH-1 gene expression, cell survival and
neurite outgrowth (Gore, 2001). It can also be due to an
increased exocytotic release of GnRH detected as neuropeptide
depletion within the neurons, a hypothesis compatible with
the modification in estrus cyclicity that we observed in
our current study. Overall, these results clearly show that
the formation of the GnRH neuroendocrine network is
vulnerable to estrogenic EDCs, leading to potential alterations
in adult reproductive function, such as puberty onset or estrus
cyclicity.
The mechanisms of action by which EE2 may affect GnRH
neuron development remain unknown. GnRH neurons are
usually described as not being directly affected physiologically
by estrogens. However, GnRH neurons express low levels
of Esr2 gene coding for estrogen receptor β (ERβ) early
in development (Skynner et al., 1999; Sharifi et al., 2002),
consistent with a possible direct regulation of EE2 on GnRH
neurons. Nonetheless, other mechanisms might occur, such as
an indirect effect through the glial microenvironment believed
to be a target of estrogenic compounds via ERs and GPR30
during development (McCarthy et al., 2002; Merlo et al.,
2007; Rao and Sikdar, 2007) and closely communicating with
developing and adult neurons (Kuo et al., 2010; Geller et al.,
2013).
We could have hypothesized that the hypothalamic circuits
governing the release of GnRH should be impaired. Kisspeptin
neurons are highly sensitive to estrogens and kisspeptin neuronal
network plays a key role in the cellular basis for estrogen
feedback action on GnRH neurons in female reproductive
function, including regulation of ovulation and estrous cyclicity
(D’anglemont De Tassigny and Colledge, 2010; Roa et al.,
2011). We did not observe any significant differences in
the number of neurons within the dimorphic kisspeptin
neurons population in the periventricular preoptic nucleus
(PVpo).
The embryonic development of kisspeptin neurons in rodents
shows no sexual dimorphism (Desroziers et al., 2012). However,
it has been clearly established that the kisspeptin neuroendocrine
network is highly dependent on gonadal steroids during
postnatal development (Clarkson et al., 2009a), and there is
some growing evidence for the susceptibility of the kisspeptin
neuroendocrine network to environmental pollution during
the postnatal period (Franceschini and Desroziers, 2013). In
female rats, perinatal exposure to 5, 15, or 50µg/kg/d EE2
did not induce significant changes in kiss-1 mRNA levels in
adulthood (Overgaard et al., 2013), as Takahashi et al. (2014)
found that a single injection of a low dose of 0.02µg/kg
EE2 at PND1 decreased hypothalamic Kiss-1 mRNA levels
at PND14. In the present study, kisspeptin immunoreactivity
was investigated in the PVpo, but not in the anteroventral
periventricular (AVPV) nucleus or arcuate nucleus (Clarkson
et al., 2009b). Therefore, though no change in kisspeptin neurons
in the PVpo was observed, we cannot rule out an alteration of
the dimorphic AVPV population or in the density of kisspeptin
fibers.
Developmental EE2 Exposure Decreased
Maternal Behavior
Females were tested as nulliparous for innate maternal care on
cross-fostered pups. Results showed that EE2-exposed females
exhibited a lower motivation to retrieve pups and a lower level
of care toward pups. Estrogenic EDCs exposure has already
been shown to alter maternal behavior. Indeed, developmental
exposure to the estrogenic compound Bisphenol A (BPA) has
previously been shown to alter maternal behavior of females
exposed as a fetus or during their own pregnancy (Palanza
et al., 2002). A recent study reported that diethylstilbestrol
(DES) exposure during pregnancy modified maternal behavior
of females and induced higher anxiety levels in adult offspring
exposed during their prenatal development and receiving care
from exposed or oil-treated mothers (Tomihara et al., 2015). This
latest study showed two possible effects of perinatal exposure
to disrupting events. The first one is a direct effect of exposure
on neural circuits leading to behavioral alteration. The second
one is an indirect effect through a disruption of the dams
nurturing behavior or anxiety level, which may lead to offspring’s
behavioral alterations. In our study, the EE2-exposed female
mice demonstrated higher anxiety in an elevated plus maze
test, as previously reported (Ryan and Vandenbergh, 2006; Ryan
et al., 2010). Therefore, disrupted maternal behavior observed
in EE2-exposed females may be attributed to a direct effect of
EE2 on target specific genes or central circuits such as POA,
directly involved in maternal care behaviors. Nevertheless, we
cannot rule out that an altered F0 maternal care could have
influenced the behavioral outcomes of their offspring behaviors
at adulthood, such as maternal care and anxiety level (Tomihara
et al., 2015).
Developmental Exposure to EE2 Altered
Socio-Sexual Recognition and Increased
Sexual Behavior
We demonstrated that EE2 treatment modified sexual behavior
of females by increasing their lordosis quotient (LQ). In rats,
Ryan et al. (2010) found that EE2 treatment at doses equivalent
to ours (0.15 and 1.5µg/kg/d) did not change the LQ, as a
higher dose (15µg/kg/d) induced a significantly lower LQ. In
their study, the LQ was monitored in ovariectomized (OVX)
and estradiol-primed females. In our study, we recorded LQs in
intact cycling females in the estrus phase to be in physiological
conditions. This difference in the testing protocol could explain
the apparently contrasting responses. Increased sexual receptivity
after developmental exposure to BPA has been reported in intact
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cycling female rats (Farabollini et al., 2002) and in C57/Bl6 strain
female mice (Naulé et al., 2014). Social and sexual behaviors in
rodents are highly gender stereotyped as a consequence of brain
sexualization occurring under steroid hormone action during
perinatal organizational and peripubertal activational periods
(McCarthy, 2008). Sexual differentiation of the female brain
has long been considered as a default state of development
in the absence of testosterone, suggesting that estrogen does
not play any feminizing role (Gorski, 1985). Recently, several
mouse knock-out (KO) models have provided evidence for a
possible active role of estrogens in female brain feminization
(Bakker et al., 2003; Brock and Bakker, 2011). Brock et al.
(2011) demonstrated that aromatase KO-mice, unable to convert
testosterone to estradiol, exhibited deficient lordosis behavior.
In these mice, peripubertal priming with estradiol restored
lordosis behavior in adulthood, thus suggesting a role of estradiol
during the peripubertal period to express typical female sexual
behaviors (Brock et al., 2011). Therefore, this raises the question
as to whether EE2 exposure induced an organizational effect
during perinatal and/or peripubertal sensitive periods leading to
a “hyperfeminizing” phenotype.
A role of estrogens in the implementation of sexually olfactory
cues in females during early development has been already
evidenced (Pierman et al., 2008). Here we tested the females for
their social-sexual preference through a choice between gonad-
intact and castrated males. Our results showed that sexually
experienced but not sexually naïve CONTROL females preferred
the gonad-intact to the castrated male. By contrast, EE2-exposed
females did not exhibit any preference, even when having
experienced sexual behavior. Mating partner recognition has
been reported to be less dependent on perinatal than on postnatal
estrogens (Bakker et al., 2007). Partner recognition for mating
behavior involves volatile and non-volatile odors detected by the
main and the accessory olfactory bulbs (MOB, AOB) (Keller et al.,
2006a). In the literature, partner recognition has been described
as being mainly supported by MOB detection, whereas lordosis
behavior involves AOB detection (Keller et al., 2006b). More
research is needed to investigate whether a failure of EE2-exposed
females to recognize adequate males is due to a disruption in the
treatment of olfactory sensory cues involved in social and sexual
interactions. Further, other downstream estrogen sensitive neural
networks involved in processing of olfactory cues stimuli such as
the sexually dimorphic medial preoptic area could be targeted by
EE2 (Henley et al., 2011).
CONCLUSION
In its report in answer to the state-of-the-science regarding
the study of endocrine disruptors (EDs), the World Health
Organization has provided recommendations and key concerns
that policy-makers should take into account. This report
highlighted the subtle effects of exposure during sensitive periods
in intra-uterine, perinatal life, juvenile, and peripubertal periods,
which may be observed throughout or only in later life,
particularly for reproductive function. The present study is an
additional piece of evidence further supporting the concept of
“developmental origins of health and diseases” and providing
evidence of neuroendocrine mechanisms underlying disruption.
Since the neuroendocrine system regulates many physiological
functions, it is not surprising that deregulation of this system
could be the cause of disruption of several physiological
functions such as reproductive and hormonal systems, growth
and metabolic homeostasis. Therefore, considering the high
sensitivity of neuroendocrine circuits and sexually dimorphic
behaviors, it is essential to consider these parameters in the
assessment of a disruptive potential of chemicals on animal and
human health.
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